Cargando…
Mechanisms of immune effector cell‐associated neurotoxicity syndrome after CAR‐T treatment
Chimeric antigen receptor T‐cell (CAR‐T) treatment has revolutionized the landscape of cancer therapy with significant efficacy on hematologic malignancy, especially in relapsed and refractory B cell malignancies. However, unexpected serious toxicities such as cytokine release syndrome (CRS) and imm...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787013/ https://www.ncbi.nlm.nih.gov/pubmed/35871757 http://dx.doi.org/10.1002/wsbm.1576 |